Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
14 September 2022 - 06:30AM
Business Wire
Johnson & Johnson (NYSE: JNJ) will host a conference call
for investors at 8:30 a.m. (Eastern Time) on Tuesday, October
18th, 2022, to review third-quarter results. Joseph J. Wolk,
Executive Vice President and Chief Financial Officer and Jessica
Moore, Vice President, Investor Relations will host the call. The
question and answer portion of the call will also include
additional members of Johnson & Johnson’s executive team.
Investors and other interested parties can access the
webcast/conference call in the following ways:
- The webcast and presentation material are accessible at Johnson
& Johnson’s website www.investor.jnj.com. A replay of the
webcast will be available approximately three hours after the
conference call concludes.
- By telephone: for both “listen-only” participants and those
financial analysts who wish to take part in the question-and-answer
portion of the call, the telephone dial-in number in the U.S. is
877-869-3847. For participants outside the U.S., the dial-in number
is 201-689-8261.
- A replay of the conference call will be available until
approximately 12:00 a.m. on November 1st. The replay dial-in number
for U.S. participants is 877-660-6853. For participants outside the
U.S., the replay dial-in number is 201-612-7415. The replay
conference ID number for all callers is 13732673.
- The press release will be available at approximately 6:45 a.m.
(Eastern Time) the morning of the conference call.
- Please refer to www.investor.jnj.com for a complete list of
currently planned earnings webcast/conference calls. Please note
the fourth-quarter date of Tuesday, January 24th, 2023.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the
foundation of vibrant lives, thriving communities and forward
progress. That’s why for more than 135 years, we have aimed to keep
people well at every age and every stage of life. Today, as the
world’s largest and most broadly-based health care company, we are
committed to using our reach and size for good. We strive to
improve access and affordability, create healthier communities, and
put a healthy mind, body and environment within reach of everyone,
everywhere. We are blending our heart, science and ingenuity to
profoundly change the trajectory of health for humanity.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220913005979/en/
Press Contact: Jake Sargent (732) 524-1090
Investor Contacts: Jessica Moore (732) 524-2955
Sarah Wood (732) 524-2617
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Mar 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2023 to Mar 2024